237 related articles for article (PubMed ID: 32265857)
1. Featured Gut Microbiomes Associated With the Progression of Chronic Hepatitis B Disease.
Chen Z; Xie Y; Zhou F; Zhang B; Wu J; Yang L; Xu S; Stedtfeld R; Chen Q; Liu J; Zhang X; Xu H; Ren J
Front Microbiol; 2020; 11():383. PubMed ID: 32265857
[TBL] [Abstract][Full Text] [Related]
2. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B Patients.
Wang J; Wang Y; Zhang X; Liu J; Zhang Q; Zhao Y; Peng J; Feng Q; Dai J; Sun S; Zhao Y; Zhao L; Zhang Y; Hu Y; Zhang M
Front Microbiol; 2017; 8():2222. PubMed ID: 29180991
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Zeng Y; Chen S; Fu Y; Wu W; Chen T; Chen J; Yang B; Ou Q
J Viral Hepat; 2020 Feb; 27(2):143-155. PubMed ID: 31600845
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis.
Shu W; Shanjian C; Jinpiao L; Qishui O
Ann Hepatol; 2022; 27(2):100676. PubMed ID: 35093600
[TBL] [Abstract][Full Text] [Related]
6. Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease.
Lin MJ; Su TH; Chen CC; Wu WK; Hsu SJ; Tseng TC; Liao SH; Hong CM; Yang HC; Liu CJ; Wu MS; Kao JH
Gut Pathog; 2023 May; 15(1):24. PubMed ID: 37218009
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failure.
Wang K; Zhang Z; Mo ZS; Yang XH; Lin BL; Peng L; Xu Y; Lei CY; Zhuang XD; Lu L; Yang RF; Chen T; Gao ZL
Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34006193
[TBL] [Abstract][Full Text] [Related]
8. Ethanol-Producing
Magdy Wasfy R; Mbaye B; Borentain P; Tidjani Alou M; Murillo Ruiz ML; Caputo A; Andrieu C; Armstrong N; Million M; Gerolami R
Microorganisms; 2023 Sep; 11(10):. PubMed ID: 37894093
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and Clinical Significance of Intestinal Microbiota in Patients with Chronic Hepatitis B Cirrhosis and Type 2 Diabetes Mellitus.
Sun X; Chi X; Zhao Y; Liu S; Xing H
J Diabetes Res; 2022; 2022():1826181. PubMed ID: 35601017
[TBL] [Abstract][Full Text] [Related]
10. Entecavir therapy reverses gut microbiota dysbiosis induced by hepatitis B virus infection in a mouse model.
Li X; Wu S; Du Y; Yang L; Li Y; Hong B
Int J Antimicrob Agents; 2020 Jul; 56(1):106000. PubMed ID: 32360229
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic potential of gut microbiome for early hepatitis B virus-related hepatocellular carcinoma.
Tang Y; Zhou H; Xiang Y; Cui F
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e167-e175. PubMed ID: 33208683
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.
Yan F; Zhang Q; Shi K; Zhang Y; Zhu B; Bi Y; Wang X
Front Cell Infect Microbiol; 2023; 13():1152987. PubMed ID: 37201112
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changes.
Li YN; Kang NL; Jiang JJ; Zhu YY; Liu YR; Zeng DW; Wang F
World J Gastroenterol; 2022 Sep; 28(35):5188-5202. PubMed ID: 36188719
[TBL] [Abstract][Full Text] [Related]
14. Compositional distinction of gut microbiota between Han Chinese and Tibetan populations with liver cirrhosis.
Huan H; Ren T; Xu L; Hu H; Liu C
PeerJ; 2021; 9():e12142. PubMed ID: 34616612
[TBL] [Abstract][Full Text] [Related]
15. The role of gut microbiota in hepatitis B disease progression and treatment.
Chen B; Huang H; Pan CQ
J Viral Hepat; 2022 Feb; 29(2):94-106. PubMed ID: 34415656
[TBL] [Abstract][Full Text] [Related]
16. Alteration of the gut microbiota associated with childhood obesity by 16S rRNA gene sequencing.
Chen X; Sun H; Jiang F; Shen Y; Li X; Hu X; Shen X; Wei P
PeerJ; 2020; 8():e8317. PubMed ID: 31976177
[TBL] [Abstract][Full Text] [Related]
17. Predicting Clinical Outcomes of Cirrhosis Patients With Hepatic Encephalopathy From the Fecal Microbiome.
Sung CM; Lin YF; Chen KF; Ke HM; Huang HY; Gong YN; Tsai WS; You JF; Lu MJ; Cheng HT; Lin CY; Kuo CJ; Tsai IJ; Hsieh SY
Cell Mol Gastroenterol Hepatol; 2019; 8(2):301-318.e2. PubMed ID: 31004827
[TBL] [Abstract][Full Text] [Related]
18. Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection.
Sun X; Pan CQ; Xing H
Hepatol Int; 2021 Oct; 15(5):1053-1067. PubMed ID: 34596865
[TBL] [Abstract][Full Text] [Related]
19. Gut Dysbiosis Associated With Hepatitis C Virus Infection.
Inoue T; Nakayama J; Moriya K; Kawaratani H; Momoda R; Ito K; Iio E; Nojiri S; Fujiwara K; Yoneda M; Yoshiji H; Tanaka Y
Clin Infect Dis; 2018 Aug; 67(6):869-877. PubMed ID: 29718124
[TBL] [Abstract][Full Text] [Related]
20. Effect of Artificial Liver Support Systems on Gut Microbiota in Patients with HBV-Related Acute-on-Chronic Liver Failure.
Song Z; Xie Q; Zhou Y; Song S; Gao Z; Lan Y; Wu Z; Cai H; Yu D; Liu C; Liang J; Xie B; Sun S
Pathogens; 2023 Aug; 12(9):. PubMed ID: 37764902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
